Aclaris Therapeutics Correlations

ACRS Stock

USD 1.67 0.05 3.09%

The current 90-days correlation between Aclaris Therapeutics and Aldeyra is 0.28 (i.e., Modest diversification). The correlation of Aclaris Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Aclaris Therapeutics Correlation With Market

Average diversification

The correlation between Aclaris Therapeutics and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Aclaris Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclaris Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Aclaris Stock please use our How to Invest in Aclaris Therapeutics guide.

Moving together with Aclaris Stock

0.79	PFE	Pfizer Inc	Pair Corr
0.66	KMDA	Kamada	Pair Corr
0.76	CAT	Caterpillar	Pair Corr
0.68	AXP	American Express	Pair Corr
0.77	BA	Boeing Earnings Call This Week	Pair Corr
0.76	CSCO	Cisco Systems Sell-off Trend	Pair Corr
0.74	JPM	JPMorgan Chase	Pair Corr
0.78	MSFT	Microsoft Earnings Call This Week	Pair Corr
0.71	DD	Dupont De Nemours Earnings Call This Week	Pair Corr
0.82	GE	GE Aerospace	Pair Corr
0.71	IBM	International Business Earnings Call Today	Pair Corr
0.62	MMM	3M Company	Pair Corr

Related Correlations Analysis

	SHC	NEOG	QGEN	BNR	ALDX	CTMX	ANAB	CLSD
SHC		0.77	-0.34	-0.47	-0.44	0.13	-0.4	0.3	SHC
NEOG	0.77		-0.36	-0.34	-0.48	0.26	-0.38	0.33	NEOG
QGEN	-0.34	-0.36		0.75	0.83	0.7	0.87	-0.44	QGEN
BNR	-0.47	-0.34	0.75		0.85	0.47	0.87	-0.64	BNR
ALDX	-0.44	-0.48	0.83	0.85		0.38	0.89	-0.51	ALDX
CTMX	0.13	0.26	0.7	0.47	0.38		0.56	-0.26	CTMX
ANAB	-0.4	-0.38	0.87	0.87	0.89	0.56		-0.47	ANAB
CLSD	0.3	0.33	-0.44	-0.64	-0.51	-0.26	-0.47		CLSD
	SHC	NEOG	QGEN	BNR	ALDX	CTMX	ANAB	CLSD

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ANAB	+ 0.89	ALDX
ANAB	+ 0.87	QGEN
ANAB	+ 0.87	BNR
ALDX	+ 0.85	BNR
ALDX	+ 0.83	QGEN
NEOG	+ 0.77	SHC

High negative correlations

CLSD	- 0.64	BNR
CLSD	- 0.51	ALDX
ALDX	- 0.48	NEOG
CLSD	- 0.47	ANAB
BNR	- 0.47	SHC
CLSD	- 0.44	QGEN

Risk-Adjusted Indicators

There is a big difference between Aclaris Stock performing well and Aclaris Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aclaris Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SHC	1.63	(0.07)	(0.02)	0.11	1.67	(1.93)	3.96	(2.98)	8.96
NEOG	3.28	(0.11)	(0.03)	0.04	4.25	(3.78)	6.83	(6.38)	28.98
QGEN	1.05	0.11	0.09	0.28	0.92	(1.25)	2.64	(1.89)	6.90
BNR	4.30	1.30	0.18	(4.42)	4.70	(4.52)	7.66	(7.67)	45.38
ALDX	3.89	1.33	0.26	0.91	4.31	(4.77)	10.04	(5.12)	31.73
CTMX	7.39	1.97	0.40	0.51	5.27	(9.49)	13.85	(10.55)	145.00
ANAB	2.56	0.45	0.14	1.11	2.33	(3.22)	7.59	(3.89)	17.51
CLSD	3.49	(1.33)	0.00	(1.06)	0.00	0.00	6.02	(6.98)	38.25

Aclaris Therapeutics Corporate Executives

Elected by the shareholders, the Aclaris Therapeutics' board of directors comprises two types of representatives: Aclaris Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aclaris. The board's role is to monitor Aclaris Therapeutics' management team and ensure that shareholders' interests are well served. Aclaris Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aclaris Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Frank Ruffo

CFO CoFounder

Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC